Clinical Trials Browser

Phase 1/2 × INDUSTRY × Sexually Transmitted Diseases × Clear all

NCT06491446 2026-02-18

Evaluating Clearance of High-Risk HPV and Safety After Administration of ABI-2280 Vaginal Inserts

Phase 1/2 Active not recruiting

Sexually Transmitted Diseases, Papillomavirus Infections

NCT02535104 2018-06-06

Safety and Efficacy Study of Topical Ranpirnase to Treat Genital Warts (HPV)

Phase 1/2 Completed

Condylomata Acuminata, Sexually Transmitted Diseases, Papillomavirus Infections